Fixing the Subscription Trap
The FTC’s Negative Option Rule do-over – and what’s at stake.
In May 2016, a class-action lawsuit was filed against Alere for, among other things, allegedly deceptively marketing INRatio products (i.e., electronic testing devices designed to help patients who take blood thinners monitor blood clotting times), including INRatio PT/INR monitors and test strips, and INRatio2 PT/INR monitors and test strips. According to the complaint, the company markets the products as “accurate” and “reliable” though it has been notified that the results produced by INRatio products are different than those produced by independent laboratories. (Andren et al v. Alere Inc., Alere Home Monitoring, Inc., and Alere San Diego, Inc., Case No. 16-cv-1255, S. D. CA.)
The FTC’s Negative Option Rule do-over – and what’s at stake.
Be wary of questionable and deceptive claims in origin stories.
Mounting lawsuits accuse Meta of breaking privacy promises.
Breaking down the fine print of this March Madness commercial.
Advertised $19.99 price deserves an official review.